Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Ewing's sarcoma family of tumors: current management.

Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Juergens H.

Oncologist. 2006 May;11(5):503-19. Review.

2.

Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.

Stegmaier S, Leuschner I, Aakcha-Rudel E, Münch P, Kazanowska B, Bekassy A, Treuner J, Koscielniak E.

Klin Padiatr. 2004 Nov-Dec;216(6):315-22.

PMID:
15565546
3.

Superficial Ewing's sarcoma family of tumors: a clinicopathological study with differential diagnoses.

Machado I, Llombart B, Calabuig-Fariñas S, Llombart-Bosch A.

J Cutan Pathol. 2011 Aug;38(8):636-43. doi: 10.1111/j.1600-0560.2011.01705.x. Epub 2011 Jun 7.

PMID:
21649689
4.

Diagnosis and treatment of Ewing's sarcoma.

Iwamoto Y.

Jpn J Clin Oncol. 2007 Feb;37(2):79-89. Epub 2007 Feb 1. Review.

PMID:
17272319
5.

Adamantinoma-like Ewing's sarcoma with EWS-FLI1 fusion gene: a case report.

Fujii H, Honoki K, Enomoto Y, Kasai T, Kido A, Amano I, Kumamoto M, Morishita T, Mii Y, Nonomura A, Takakura Y.

Virchows Arch. 2006 Nov;449(5):579-84. Epub 2006 Oct 3.

PMID:
17016721
6.

Advances in Ewing's sarcoma research: where are we now and what lies ahead?

Ordóñez JL, Osuna D, Herrero D, de Alava E, Madoz-Gúrpide J.

Cancer Res. 2009 Sep 15;69(18):7140-50. doi: 10.1158/0008-5472.CAN-08-4041. Epub 2009 Sep 8. Review.

7.

Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.

Dunst J, Ahrens S, Paulussen M, Rübe C, Winkelmann W, Zoubek A, Harms D, Jürgens H.

Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):379-84.

PMID:
9788419
8.

The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors.

Grier HE.

Pediatr Clin North Am. 1997 Aug;44(4):991-1004. Review.

PMID:
9286296
9.

Role of fusion subtype in Ewing sarcoma.

Barr FG, Meyer WH.

J Clin Oncol. 2010 Apr 20;28(12):1973-4. doi: 10.1200/JCO.2009.27.2161. Epub 2010 Mar 22. No abstract available.

PMID:
20308653
11.

Ewing's sarcoma: general insights from a rare model.

Davis S, Meltzer PS.

Cancer Cell. 2006 May;9(5):331-2.

12.

Treatment of Ewing's sarcoma using an antisense oligodeoxynucleotide to regulate the cell cycle.

Asami S, Chin M, Shichino H, Yoshida Y, Nemoto N, Mugishima H, Suzuki T.

Biol Pharm Bull. 2008 Mar;31(3):391-4.

13.

Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.

Miser JS, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Grier HE.

J Clin Oncol. 2004 Jul 15;22(14):2873-6.

PMID:
15254055
14.

The Biology of Ewing sarcoma.

Riggi N, Stamenkovic I.

Cancer Lett. 2007 Aug 28;254(1):1-10. Epub 2007 Jan 23. Review.

PMID:
17250957
15.

[Ewing's tumours, genetic and cellular aspects].

Delattre O.

Pathol Biol (Paris). 2008 Jul;56(5):257-9. doi: 10.1016/j.patbio.2008.03.005. Epub 2008 May 15. French.

PMID:
18485618
16.

GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.

Luo W, Gangwal K, Sankar S, Boucher KM, Thomas D, Lessnick SL.

Oncogene. 2009 Nov 19;28(46):4126-32. doi: 10.1038/onc.2009.262. Epub 2009 Aug 31.

PMID:
19718047
17.

STAT3 is activated in a subset of the Ewing sarcoma family of tumours.

Lai R, Navid F, Rodriguez-Galindo C, Liu T, Fuller CE, Ganti R, Dien J, Dalton J, Billups C, Khoury JD.

J Pathol. 2006 Apr;208(5):624-32.

PMID:
16463269
18.

DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.

García-Aragoncillo E, Carrillo J, Lalli E, Agra N, Gómez-López G, Pestaña A, Alonso J.

Oncogene. 2008 Oct 9;27(46):6034-43. doi: 10.1038/onc.2008.203. Epub 2008 Jun 30.

PMID:
18591936
19.

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.

Wexler LH, DeLaney TF, Tsokos M, Avila N, Steinberg SM, Weaver-McClure L, Jacobson J, Jarosinski P, Hijazi YM, Balis FM, Horowitz ME.

Cancer. 1996 Aug 15;78(4):901-11. Erratum in: Cancer 1997 Feb 15;79(4):867.

20.

A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.

Donaldson SS, Torrey M, Link MP, Glicksman A, Gilula L, Laurie F, Manning J, Neff J, Reinus W, Thompson E, Shuster JJ.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):125-35.

PMID:
9747829

Supplemental Content

Support Center